Quantitative evaluation and modeling of two-dimensional neovascular network complexity: the surface fractal dimension by Grizzi, Fabio et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Cancer
Open Access Research article
Quantitative evaluation and modeling of two-dimensional 
neovascular network complexity: the surface fractal dimension
Fabio Grizzi*1,2, Carlo Russo1,2, Piergiuseppe Colombo3, 
Barbara Franceschini1,2, Eldo E Frezza4, Everardo Cobos5 and 
Maurizio Chiriva-Internati6
Address: 1Scientific Direction, Istituto Clinico Humanitas, Via Manzoni 56 – 20089 Rozzano, Milan, Italy, 2"Michele Rodriguez" Foundation-
Institute for Quantitative Measures in Medicine, Via Ludovico Di Breme 79 – 20100 Milan Italy, 3Department of Pathology, Istituto Clinico 
Humanitas, Via Manzoni 56 – 20089 Rozzano, Milan, Italy, 4Department of Surgery, Texas Tech University Health Science Center and the 
Southwest Cancer Treatment and Research Center, 79430 Lubbock, Texas, USA, 5Department of Internal Medicine, Texas Tech University Health 
Science Center and the Southwest Cancer Treatment and Research Center, 79430 Lubbock, Texas, USA and 6Department of Microbiology and 
Immunology, Texas Tech University Health Science Center and the Southwest Cancer Treatment and Research Center, 79430 Lubbock, Texas, USA
Email: Fabio Grizzi* - fabio.grizzi@humanitas.it; Carlo Russo - carlo.russo@humanitas.it; 
Piergiuseppe Colombo - piergiuseppe.colombo@humanitas.it; Barbara Franceschini - barbara.franceschini@humanitas.it; 
Eldo E Frezza - Eldo.Frezza@ttuhsc.edu; Everardo Cobos - Everardo.Cobos@ttuhsc.edu; Maurizio Chiriva-
Internati - maurizio.chirivainternati@ttuhsc.edu
* Corresponding author    
Abstract
Background:  Modeling the complex development and growth of tumor angiogenesis using
mathematics and biological data is a burgeoning area of cancer research. Architectural complexity
is the main feature of every anatomical system, including organs, tissues, cells and sub-cellular
entities. The vascular system is a complex network whose geometrical characteristics cannot be
properly defined using the principles of Euclidean geometry, which is only capable of interpreting
regular and smooth objects that are almost impossible to find in Nature. However, fractal
geometry is a more powerful means of quantifying the spatial complexity of real objects.
Methods: This paper introduces the surface fractal dimension (Ds) as a numerical index of the two-
dimensional (2-D) geometrical complexity of tumor vascular networks, and their behavior during
computer-simulated changes in vessel density and distribution.
Results: We show that Ds significantly depends on the number of vessels and their pattern of
distribution. This demonstrates that the quantitative evaluation of the 2-D geometrical complexity
of tumor vascular systems can be useful not only to measure its complex architecture, but also to
model its development and growth.
Conclusions: Studying the fractal properties of neovascularity induces reflections upon the real
significance of the complex form of branched anatomical structures, in an attempt to define more
appropriate methods of describing them quantitatively. This knowledge can be used to predict the
aggressiveness of malignant tumors and design compounds that can halt the process of angiogenesis
and influence tumor growth.
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Background
The term "angiogenesis" defines the fundamental process
of the development and growth of new blood vessels from
the pre-existing vasculature, and is essential for reproduc-
tion, development and wound repair [1]. Under these
conditions, it is highly regulated: i.e. "turned on" for brief
periods of time (days) and then completely inhibited.
The cyclic nature of the microvascular bed in the corpus
luteum provides a unique experimental model for exam-
ining the discrete physiological steps of angiogenesis in
the life cycle of endothelial cells which, together with peri-
cytes (supportive vascular smooth muscle cells), carry all
of the genetic information necessary to form tubes,
branches and entire capillary networks.
However, many human diseases (including solid tumors)
are driven by persistently up-regulated angiogenesis [1].
In some non-malignant processes, such as pyogenic gran-
uloma or keloid formation [2], angiogenesis is prolonged
but still self-limited; however, this is not true of tumor ang-
iogenesis which, once begun, continues indefinitely until
the entire tumor is eradicated or the host dies. Without
blood vessels, tumors cannot grow beyond a critical size
(1–2 mm) or metastasize to another organ.
Angiogenesis is one of the most complex dynamic proc-
esses in biology, and is highly regulated by a balance of
pro- and anti-angiogenic molecules. It is now widely
accepted that the "angiogenic switch" is "off" when the
effects of pro-angiogenic molecules is balanced by that of
anti-angiogenic molecules, and "on" when the net bal-
ance is tipped in favor of angiogenesis [1,3]. Pro- and anti-
angiogenic molecules can be secreted from cancer cells,
endothelial cells, stromal cells, blood, and the extra-cellu-
lar matrix [4,5], the relative contributions of which are
likely to change with tumor type and site, as well as with
tumor growth, regression and relapse [1].
Although considerable advances have been made in our
molecular and cellular knowledge of the promotion, medi-
ation and inhibition of angiogenesis, very little is known
about its underlying complex dynamics. Vasculature and
more generally tubular organs develop in a wide variety of
ways involving many cell processes [6-8].
In mathematical terms, angiogenesis is a non-linear
dynamic system that is discontinuous in space and time, but
advances through qualitatively different states. The word
state defines the configuration pattern of the system at any
given moment, and a dynamic system can be represented
as a set of different states and a number of transitions from
one state to another over a certain time interval [9,10].
At least seven critical steps have so far been identified in
the sequence of angiogenic events on the basis of sprout
formation: a) endothelial cells are activated by an ang-
iogenic stimulus; b) the endothelial cells secrete proteases
to degrade the basement membrane and extra-cellular
matrix;  c)  a capillary sprout is formed as a result of
directed endothelial cell migration, d) grows by means of
cell mitoses and migration, and e) forms a lumen and a
new basement membrane; f) two sprouts come together
to form a capillary loop; and g) second-generation capil-
lary sprouts begin to form [1,11,12] (Fig. 1).
The progression of these states generates a complex rami-
fied structure that irregularly fills the surrounding envi-
ronment (Fig. 2). The main feature of the newly generated
vasculature is the structural diversity of the vessel sizes,
shapes and connecting patterns.
Tumor vessels are structurally and functionally abnormal
[1,3]: unlike normal vessels, they are highly disorganized,
tortuous and dilated, and have uneven diameters, and
excessive branching and shunts. This may be mainly due
to the heterogeneous distribution of angiogenic regula-
tors, such as vascular-endothelial growth factor (VEGF),
basic fibroblastic growth factor (bFGF) and angiopoietin
[5,13], leading to chaotic tumor blood flow, and hypoxic
and acidic tumoral regions [5,14-16]. Moreover, although
it is commonly believed that the endothelial cells making-
up tumor vessels are genetically stable, diploid cells (and
thus different from genetically unstable neoplastic cells),
tumor vasculature seems to be much more unpredictable
[17].
These conditions all reduce the effectiveness of treat-
ments, modulate the production of pro- and anti-ang-
iogenic molecules, and select a subset of more aggressive
cancer cells with higher metastatic potential [1].
A large number of clinical trials of anti-angiogenic thera-
pies are being conducted throughout the world, but inves-
tigators are still concerned about how to achieve the
maximum benefit from them and how to monitor patient
response. There are currently no markers of the net ang-
iogenic activity of a tumor that can help investigators to
design specific anti-angiogenic treatment strategies [5,18],
but it is reasonable to resume that the quantification of
various aspects of tumor vasculature may provide an indi-
cation of angiogenic activity.
One often-quantified element of tumor vasculature is
microvessel density (MVD), which is used to allow a his-
tological assessment of tumor angiogenesis. The results of
studies carried out over the last decade have suggested the
value of using tumor MVD as a prognostic index in a wide
variety of solid cancers, and it has also recently beenBMC Cancer 2005, 5:14 http://www.biomedcentral.com/1471-2407/5/14
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assumed that MVD may reveal the degree of angiogenic
activity in a tumor. On the basis of these assumptions, the
quantification of MVD is thought to be a surrogate marker
of the efficacy of anti-angiogenic agents as well as a means
of assessing which patients are good candidates for anti-
angiogenic therapy. However, MVD has a number of sub-
stantial limitations, mainly due to the complex biology
characterizing tumor vasculature [17], and the highly
irregular geometry that the vascular system assumes in real
space, which cannot be measured using the principles of
Euclidean geometry because it is only capable of interpret-
ing regular and smooth objects that are almost impossible
to find in Nature.
However, quantitative descriptors of its geometrical com-
plexity can be usefully abstracted from the fractal geome-
try introduced by Benoit Mandelbrot in 1975 [20,21]. We
here discuss the surface fractal dimension (DS) as a quanti-
tative index of the 2-D geometrical complexity of vascular
networks and their behavior during computer-simulated
changes in vessel density and distribution.
Geometrical properties of a vascular network
The human vascular system can be geometrically depicted
as a complex fractal network of vessels that irregularly
branch with a systematic reduction in their length and
diameter [19].
Fractal objects are mainly characterized by four properties:
a) the irregularity of their shape; b) the self-similarity of
their structure; c) their non-integer or fractal dimension;
and d) scaling, which means that the measured properties
depends on the scale at which they are measured [22].
One particular feature of fractal objects is that the schemas
defining them are continuously repeated at decreasing
orders of magnitude, and so the form of their component
parts is similar to that of the whole [20,21]: this property
Angiogenesis is a complex dynamic process that evolves through different states and a number of transitions between two suc- cessive states Figure 1
Angiogenesis is a complex dynamic process that evolves through different states and a number of transitions between two suc-
cessive states. At least seven critical steps have so far been identified in the sequence of angiogenic events on the basis of 
sprout formation.BMC Cancer 2005, 5:14 http://www.biomedcentral.com/1471-2407/5/14
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is called self-similarity. Unlike geometrical self-similarity,
which only concerns mathematical fractal objects in
which every smaller piece is an exact duplicate of the
whole (e.g. Koch's snowflake curve, Sierpinski's triangle
and Menger's sponge), statistical self-similarity concerns all
complex anatomical systems, including tumor vascula-
ture. The smaller pieces constituting anatomical entities
are rarely identical copies of the whole, but more fre-
quently "similar" to it and, in such systems, the statistical
properties of the pieces are proportional to the statistical
properties of the whole [23].
Dimension is a numerical attribute of an object that does
not depend on its process of generation, and has been
defined in two ways. The first is the topological or Euclidean
dimension (Fig. 3), which assigns an integer to every point
or set of points in Euclidean space (E): 0 to a point (defined
as that which has no part); 1 to a straight line (defined as a
length without thickness), 2 to a plane surface (defined as
having length and thickness, but no depth); and 3 to three-
dimensional figures (a volume defined by length, thickness
and depth). The second was introduced by the mathema-
ticians Felix Hausdorff and Abram S. Besicovitch, who
attributed a real number to every natural object in E lying
between the topological dimensions 0 and 3 (Fig. 3).
Benoit Mandelbrot uses the symbol Dγ to indicates the
topological dimension, and the symbol D to indicate that
of Hausdorff-Besicovitch (also called the fractal dimen-
sion). The Dγ and D of all Euclidean figures are coincident
(Dγ = D), but this is not true of fractal objects in which D
is always >Dγ.
As no anatomical entity corresponds to a regular Eucli-
dean figure, their dimension is always expressed by a non-
integer number falling between two integer topological
dimensions. In our case (Fig. 2), the vascular network has
a dimension lying between 2 (plane surface) and 3 (vol-
ume), and any two-dimensional section of a vascular sys-
tem (as in the case of a histological section) has a
dimension lying between 0 (the dimension of a single iso-
lated point) and 2 when the sectioned vessels entirely fill
a plane surface (Figs. 3 and 4).
Anatomical structures are also hierarchical systems that
operate at different spatial and temporal scales, and differ-
ent patterns can change, appear or disappear depending
on the scale of magnification [22]. A fundamental charac-
teristic is that the process operating at a given scale cannot
be important at higher or lower scales [23].
The irregularity and self-similarity underlying scale
changes are the main attributes of the architectural com-
plexity of both normal and pathological biological enti-
ties [22-26]. In other words, the shape of a self-similar
object does not change when the scale of measure changes
The space-filling property of the vascular system is quantified by the fractal dimension (D), which falls between two topological  integer dimensions Figure 2
The space-filling property of the vascular system is quantified by the fractal dimension (D), which falls between two topological 
integer dimensions. A. A Euclidean three-dimensional space (i.e. a cube) can contain a branching structure (i.e. the vascular sys-
tem) without this entirely filling its internal space. B. Two-dimensional sectioning of the vascular network makes it possible to 
identify a variable number of vessels depending on the geometrical complexity of the system at any particular level of sectioning. 
C. The geometrical complexity of a 2-D section (s1, s2, s3) of the vascular network depends in the number of sectioned vessels 
and their distribution pattern.BMC Cancer 2005, 5:14 http://www.biomedcentral.com/1471-2407/5/14
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because every part of it is similar to the original object;
however, the magnitude and other geometrical parameters
(e.g. the outline perimeter) of an irregular object differ
when inspected at increasing resolutions that reveal an
increasing number of details [25]. Over the last decade,
accumulating experimental evidence has shown that the
fractal patterns or self-similar structures of biological tis-
sues can only be observed within the scaling window of an
experimentally established measure of length ε1-ε2 (Fig.
4), within which experimental data sets follow a straight
line with a slope (1-D): i.e. the fractal dimension remains
invariant at different magnifications [20-27].
Methods
Computer-aided modeling of two-dimensional vascular 
tree complexity
We have developed a computer model to simulate the
geometrical complexity of a histological two-dimensional
section of a tumor vascular tree that automatically gener-
ates an unlimited number of images with a changeable
density of vessels irregularly distributed on a planar
surface.
In order to simplify the model, we considered all of the
vessels as rounded, unconnected objects of equal
magnitude (Fig. 5). As the parameters of a model must be
as few as possible and it is necessary to reduce mathemat-
ical complexity [28-30], we included only two variables:
a) the number of vessels; and b) their distribution in the
surrounding environment. The vessel distribution pat-
terns were randomly generated using different time-
dependent seeds for random number function
generation.
One thousand images were automatically generated for
each vessel density (from five to 50 vessels, with the
number being increased by five in each group), and their
DS were estimated using the box-counting method [22].
DS was automatically estimated using the equation:
where ε is the side-length of the box, and N(ε) the smallest
number of boxes of side ε required to completely contain
the irregular object (Fig. 4).
As the zero limit cannot be applied to biological images,
DS was estimated by means of the equation:
Fractal dimensioning of the 2-D complexity of a vascular network Figure 3
Fractal dimensioning of the 2-D complexity of a vascular network. The figure shows four idealized cross-sectioned vascular pat-
terns that not only have a different number of vessels, but also clearly different distributions: the geometrical complexity arising 
from these two variables determines the value of the surface fractal dimension.
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(2)   DS = d
where d is the slope of the graph of log [N(ε)] against log
(1/ε), in a fixed range of side-lengths (ε 1-ε 2) empirically
evaluated by visualization [20-29].
Statistical analysis
All of the data are expressed as mean values ± standard
deviation, and the results were analysed using the Statis-
tica software package (StatSoft Inc. Tulsa, USA). Unvaried
analysis was performed by means of the Student t  as
required for parametric variables. p  values of less than
0.05 were considered statistically significant.
Results
The computer-aided simulations showed that different DS
values can be obtained for images with the same vessel
density (Fig. 6). As the only variable in these images is the
vessel distribution pattern, DS depends on the irregular
arrangement of the vessels in the surrounding environ-
ment.  DS  also significantly increased (p  <0.05) when
higher vessel densities were considered in the system (Fig.
Computer-aided estimate of the surface fractal dimension (Ds) of a vascular network in 2-D biopsy sections Figure 4
Computer-aided estimate of the surface fractal dimension (Ds) of a vascular network in 2-D biopsy sections. A. Hepatocellular 
carcinoma section stained with antibodies raised against CD31 (Dako, Milan, Italy) that specifically react with vessels. B. Image 
segmentation: immunopositive vessels are specifically selected on the basis of the similarity of the color of adjacent pixels. C. 
Determination of Ds using the box-counting algorithm. Briefly, the method counts the number of boxes of length ε required to 
cover the object being measured, indicated as N(ε). D. Prototypical curve obtainable using the box-counting method that high-
lights the so-called fractal windows ranged by box size ε1 and ε2, and represents the appropriate region in which to estimate 
the dimension. Box sizes of more than ε2 approach the size of the image until one box covers it completely, at which point N(ε) 
= 1 and the slope = 0. Box sizes smaller than ε1 approach a single pixel or the resolution of the image: in this region, box count-
ing simply gives the area of the image.BMC Cancer 2005, 5:14 http://www.biomedcentral.com/1471-2407/5/14
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6) because of the greater space filled by the vascular com-
ponent (as shown in Fig. 3); the increased density of the
vessels reduces the variability in their space-filling proper-
ties, and thus the standard deviation (Fig. 6).
Discussion and conclusions
One of the most important and distinctive characteristics
of biological systems is the complexity of their shape (geo-
metrical or spatial complexity) and functions (behavioral
complexity). Complexity is a real quality of organized bio-
logical matter that is mainly manifested in the living
world as diversity and organization. No two anatomical sys-
tems are exactly alike because of the enormous variability
not only between the different members of a population,
but also between the component parts of an organism.
The word complexity has long been used descriptively in
order to describe, for example, a large number of genes or
cellular interconnections [33], but complexity can also
reside in the structure of a system (i.e. an intricate architec-
ture or the existence of many different component parts
with varying interactions) or its non-linear functions (i.e.
physiological rhythms are rarely strictly periodic but fluc-
tuate irregularly over time) [34].
The vascular system is a complex network consisting of
branched tubes of different sizes that are irregularly settled
in the surrounding environment [6,7]. This geometrical
characteristic highlights the complexity of its generating
process in space and time, and greatly biases any quantita-
tive method that tends to idealize it as a smooth and reg-
ular Euclidean object.
Computer-aided procedure used to quantify the surface fractal dimension of a simulated two-dimensional image of the vascular  system Figure 5
Computer-aided procedure used to quantify the surface fractal dimension of a simulated two-dimensional image of the vascular 
system. Prototypical 2-D simulated microscopy images of the vascular system with different vessel numbers and distribution 
were automatically generated, and their Ds was determined.
The behavior of Ds during a simulated increase in vessel  density Figure 6
The behavior of Ds during a simulated increase in vessel den-
sity. The graph shows that different Dsvalues can be obtained 
for images with the same vessel density. As the only variable 
in these images is their distribution pattern, Ds depends on 
the irregular arrangement of the vessels in the surrounding 
environment (note the standard deviation of each cell density 
group). Ds also increases significantly when a higher vessel 
density is introduced into the system because of the greater 
space filled by the vascular component. The increase in vessel 
density reduces the variability of their space-filling properties, 
thus reducing the standard deviation.BMC Cancer 2005, 5:14 http://www.biomedcentral.com/1471-2407/5/14
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However, both normal and tumor vasculature can more
properly be considered fractal objects because of their irreg-
ular shape (spatial conformation), self-similar structure,
non-integer dimension and dependence on the scale of
observation (scaling effect) [19,35-37].
We here discuss the estimate of DS as a quantitative index
of the 2-D spatial complexity of the vascular tree, in order
to provide a closer-to-reality measure of this complex ana-
tomical entity (Figs. 3 and 4).
The theory underlying DS  was abstracted from fractal
geometry, which is also called the geometry of irregularity
[20,21]. The concept of spatial conformation has played a
fundamental role in the study of biological
macromolecules in chemistry (particularly biochemistry)
since the early 1950s. However, it has only been intro-
duced in the science of morphology as theoretical morphology,
which studies extant organismal forms (complex structures
of interdependent and subordinate elements whose rela-
tionships and properties are largely determined by their
function in the whole) as a subset of the range of theoret-
ically possible morphologies [32].
The significance of DS also comes from the fact that, like
any other complex biological system, the vascular tree
cannot be correctly quantified by measuring its individual
properties (i.e. micro-vessel density, MVD). DS is a param-
eter that depends on: a) the number of vessels; b) the spa-
tial relationships between the vascular components; and
c) the interactions between the vascular components and
the surrounding environment. In other words, its estimate
is "ecologically" important because it provides a quantita-
tive index of the "habitat structure".
As computer models are crucial for scientific procedures,
and the modeling process itself represents the hypotheti-
cal-deductive approach in science [30-32], we developed
a simple computer-aided model capable of generating an
unlimited number of 2-D images of a simulated vascular
network. The model was simplified by using a minimum
amount of mathematical complexity and only two varia-
bles: the number of vessels and their pattern of distribu-
tion. A total of 10,000 images showing a different number
of unconnected vessels irregularly distributed on a planar
surface were automatically generated (Fig. 5) and, inter-
estingly, it was found that DS increased with the number
of vessels making up the system (Fig. 6); furthermore, its
value changed when the same number of vessels were dif-
ferently distributed in the surrounding environment.
In other words, it is plausible that an equal number of ves-
sels may have different space-filling properties depending
on their distribution pattern. These results suggest the use-
fulness of this model when comparing real vasculature
configurations in order to explore the morphological var-
iability that can be produced in nature, as it is now well
known that aberrant vascular architectures in tumors may
affect the uniform delivery of specific drugs to all cancer
cells [15].
The model also suggests that:
a) Ds can be an estimate of the 2-D geometrical complex-
ity of the vascular system. As 2-D vascular complexity
depends on the number of vessels and their distribution
pattern, the use of MVD quantification alone to measure
the angiogenic dependence of a tumor is strongly biased
because the number of vessels does not reflect the number
of tumor cells that can be supported by a vessel. Moreover
the metabolic needs of cancer cells vary with the tissue of
origin and change with tumor progression [18].
b) DS depends on the degree of vessel contiguity and conti-
nuity. These two geometrical properties determine what is
called the intercapillary distance, and are not only involved
in the spatial complexity of tumor vasculature, but also
reflect the inviolable demand of a growing tumor for suf-
ficient levels of nutrition and oxygen exchange. Inter-cap-
illary distances are locally defined by the net balance
between pro- and anti-angiogenic molecules in each micr-
otissue region, as well as by non-angiogenic factors such
as the oxygen and nutrient consumption rates of tumor
cells. In normal tissue, vessel density fairly accurately
reflects cell metabolic demands because evolutionary
pressures have led to close and efficient coupling between
vascular supply and metabolic needs. In tumors, the close
coupling between vascular density and oxygen or nutrient
consumption (i.e.  the environment) may be loosened
[18], thus altering not only the number of vessels but also
the whole vascular architecture [15,38].
c) DS falls between 0 (corresponding to the Euclidean
dimension of a point) and 2 (the dimension of a plane).
The more DS tends towards 2, the more the analyzed vas-
cular configuration tends to fill a 2-D space and the
greater its geometrical complexity.
In conclusion, the present study indicates that the complex
geometry of tumor vasculature and its well-known biolog-
ical characteristics [18] mean that vascular network can-
not be measured on the basis of MVD estimates alone.
These findings also support the findings of various
authors who have shown the uselessness of MVD as a pre-
dictor of anti-angiogenic treatment efficacy or for stratify-
ing patients in therapeutic trials [14,39-41].
Scientific knowledge develops through the evolution of
new concepts, and this process is usually driven by new
methodologies that provide previously unavailableBMC Cancer 2005, 5:14 http://www.biomedcentral.com/1471-2407/5/14
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observation. The potential broad applicability of the pro-
posed quantitative index makes it possible to explore the
range of the morphological variability of vasculature that
can be produced in nature, thus increasing its diagnostic
importance in cancer research.
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